Page last updated: 2024-12-07

5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123808
CHEMBL ID398231
SCHEMBL ID64271
MeSH IDM0109378

Synonyms (21)

Synonym
1,1'-bis(4-anilino-5-naphthalenesulfonic acid)
(1,1'-binaphthalene)-5,5'-disulfonic acid, 4,4'-bis(phenylamino)-
4,4'-bis(1-anilino-8-naphthalenesulfonate)
4,4'-bis(8-phenylamino)naphthalene-1-sulfonate
5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)
bis(1,8-anilinonaphthalenesulfonate)
5,5-bis(ans)
4,4'-bans
63741-13-9
CHEMBL398231
8-anilino-5-(4-anilino-5-sulfonaphthalen-1-yl)naphthalene-1-sulfonic acid
SCHEMBL64271
4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid
SBYQPEKNMQWJQO-UHFFFAOYSA-N
bis - (5,5') - 8 - anilino - 1 - naphthalene sulfonic acid dipotassium salt
DTXSID40980256
4,4'-dianilino[1,1'-binaphthalene]-5,5'-disulfonic acid
bis-ans (potassium salt)
4,4'-bis(phenylamino)[1,1'-binaphthalene]-5,5'-disulfonic acid
R3N4JW37JT
[1,1'-binaphthalene]-5,5'-disulfonic acid, 4,4'-bis(phenylamino)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Choline O-acetyltransferaseHomo sapiens (human)Ki3.00000.10001.30003.0000AID52124
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
phosphatidylcholine biosynthetic processCholine O-acetyltransferaseHomo sapiens (human)
neurotransmitter transportCholine O-acetyltransferaseHomo sapiens (human)
neuromuscular synaptic transmissionCholine O-acetyltransferaseHomo sapiens (human)
acetylcholine biosynthetic processCholine O-acetyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
choline O-acetyltransferase activityCholine O-acetyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
nucleusCholine O-acetyltransferaseHomo sapiens (human)
cytosolCholine O-acetyltransferaseHomo sapiens (human)
synapseCholine O-acetyltransferaseHomo sapiens (human)
cytoplasmCholine O-acetyltransferaseHomo sapiens (human)
neuron projectionCholine O-acetyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID475510Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 2 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID52124Inhibition of choline acetyltransferase isolated from squid head ganglia1981Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
Interaction of aromatic dyes with the coenzyme A binding site of choline acetyltransferase.
AID475509Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 2 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID290817Inhibition of Escherichia coli RecA by ADP-linked fluorescent ATPase assay2007Bioorganic & medicinal chemistry letters, Jun-15, Volume: 17, Issue:12
Directed molecular screening for RecA ATPase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (208)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (8.65)18.7374
1990's71 (34.13)18.2507
2000's93 (44.71)29.6817
2010's23 (11.06)24.3611
2020's3 (1.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.54 (24.57)
Research Supply Index5.36 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other211 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]